Furthermore, as the primary mechanism of genotoxic radio- and chemotherapy involves the p53-mediated activation of the mitochondrial death pathway, tumor cells develop therapy resistance by disabling this pathway e.g., via overexpression of antiapoptotic Bcl-2 proteins [33, 57]. This evidence concerns the gene BCL2 and neoplasm.